New diabetes clinical trial: Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes
- Get link
- X
- Other Apps
Published on: January 28, 2020 at 10:30PM
Conditions: Diabetes Mellitus, Type 1; Type 1 Diabetes; Postprandial Hyperglycemia
Interventions: Drug: Rapid-Acting Insulin; Drug: Placebo; Drug: Pramlintide Acetate; Device: Artificial Pancreas
Sponsors: McGill University; Canadian Institutes of Health Research (CIHR)
Not yet recruiting
https://ift.tt/2uJiY6X
Conditions: Diabetes Mellitus, Type 1; Type 1 Diabetes; Postprandial Hyperglycemia
Interventions: Drug: Rapid-Acting Insulin; Drug: Placebo; Drug: Pramlintide Acetate; Device: Artificial Pancreas
Sponsors: McGill University; Canadian Institutes of Health Research (CIHR)
Not yet recruiting
https://ift.tt/2uJiY6X
Comments
Post a Comment